Isosorbide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Isosorbide. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Patients | 102% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Isosorbide Mononitrate Extended-Release Tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.
Source: FDA labeling via NIH DailyMed (set 8c104eaa…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.